Imed Pharmaceuticals (India) Private Limited

Imed Pharmaceuticals (India) Private Limited - healthcare in Hubli, Karnataka, India. FY 2026 financials & compliance.
CIN U24200KA2008PTC047159 Incorporated 15 July 2008 ROC Bangalore HQ Hubli, Karnataka, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2015
₹7.24 Cr
▼ 30% YoY
Net loss · FY 2015
₹4.53 Cr
Net margin -62.6%
EBITDA · FY 2015
-₹8.41 Cr
EBITDA margin -116.2%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹89.92 Lakh
Issued & subscribed
Open charges
₹8.75 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings

About Imed Pharmaceuticals (India) Private Limited

Data last updated:

Imed Pharmaceuticals (India) Private Limited is a private limited company based in Hubli, Karnataka, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 15 July 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24200KA2008PTC047159. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹89.92 Lakh. It is led by directors Narasappa Swamy Bhavikatti and Gayathri Bhavikatti.

Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office is at Lg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029.

As per the financials filed for FY 2015, the company reported a revenue of ₹7.24 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹4.53 Cr (net margin -62.6%) and EBITDA of -₹8.41 Cr (EBITDA margin -116.2%).

As per MCA filings, the company has open charges of ₹8.75 Cr on record. Court records list 8 cases involving the company, including 8 filed against it; 1 case is pending.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U24200KA2008PTC047159
Registration Number 047159
Incorporation Date 15 July 2008
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2015
Date of Balance Sheet 31 March 2015
Compliance Status Active Non-Compliant

Contact details

Imed Pharmaceuticals (India) Private Limited's registered office is in Hubli, Karnataka. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Lg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Imed Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
Imed Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Imed Pharmaceuticals (India) Private Limited

FY 2015 filings available

Imed Pharmaceuticals (India) Private Limited reported revenue of ₹7.24 Cr (down 30% YoY) for FY 2015.

Revenue · FY 2015
₹7.24 Cr ▼ 30%
Net loss · FY 2015
₹4.53 Cr margin -62.6%
EBITDA · FY 2015
-₹8.41 Cr margin -116.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 30%

Revenue fell 30% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹7.24 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8.41 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.53 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2014-15
Profitability
EBITDA Margin-116.2%
Net Profit Margin-62.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Imed Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Imed Pharmaceuticals (India) Private Limited

Imed Pharmaceuticals (India) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narasappa Swamy BhavikattiDirector15 Jul 200818 Years 3 MonthsCurrent
Gayathri BhavikattiDirector15 Jul 200818 Years 3 MonthsCurrent

Auditor

Imed Pharmaceuticals (India) Private Limited is audited by N S AYYANAGOUDAR & CO for the financial year 2015.

Auditor firmFinancial yearFirm registration number
N S AYYANAGOUDAR & COFY 2015000280S

Shareholding

The shareholding of Imed Pharmaceuticals (India) Private Limited is on record for FY 2015, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2015
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Imed Pharmaceuticals (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Krishnakumar G. Agrawal on Behalf of Kare Labs Private Limited₹5.00 Cr
Axis Bank Limited₹3.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Dec 201210394589Axis Bank Limited₹3.75 CrOpen
21 Aug 201210380225Krishnakumar G. Agrawal on Behalf of Kare Labs Private Limited₹5 CrOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Imed Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Imed Pharmaceuticals (India) Private Limited has 1 active EPFO establishment as of Mar 31, 2024.

Active EPFO establishments
1

GST

Imed Pharmaceuticals (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Imed Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

Imed Pharmaceuticals (India) Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Deepak Arjundas Kukreja ceased to be Director on 31 Mar 2015.

AGM
Imed Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Filing
Imed Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Bangalore.
Ceased
Deepak Arjundas Kukreja ceased to be Director.
Ceased
Sanjay Kukreja Cheturam ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.75 Cr with Charge ID 10394589 was registered on 20 Dec 2012.
Charges
A charge with Krishnakumar G. Agrawal On Behalf Of Kare Labs Private Limited amounted to Rs. 5.00 Cr with Charge ID 10380225 was registered on 21 Aug 2012.
Appointed
Gayathri Bhavikatti was appointed as Director.
Appointed
Narasappa Swamy Bhavikatti was appointed as Director.
Incorporation
15 Jul 2008
Imed Pharmaceuticals (India) Private Limited was registered on 15 Jul 2008 with Roc Bangalore & aged 18 years 3 months as per MCA records.

Frequently asked questions

Imed Pharmaceuticals (India) is an active private limited company based in Hubli, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 15 July 2008 (18+ years old) and is registered under CIN U24200KA2008PTC047159.

Imed Pharmaceuticals (India) has 2 current directors:

The latest financial statements of Imed Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.

No. Imed Pharmaceuticals (India) has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Imed Pharmaceuticals (India) is U24200KA2008PTC047159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Imed Pharmaceuticals (India) has 8 court cases on record: 8 filed against it. 1 is pending.

Imed Pharmaceuticals (India) was incorporated on 15 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.

Deepak Arjundas Kukreja ceased to be Director on 31 Mar 2015. Sanjay Kukreja Cheturam ceased to be Director on 31 Mar 2015. Gayathri Bhavikatti was appointed as Director on 15 Jul 2008. Imed Pharmaceuticals (India) has 4 board changes on record in total.

The registered office of Imed Pharmaceuticals (India) is at Lg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029.

Imed Pharmaceuticals (India) operates in the healthcare industry, in the preventive health services segment.